The global Dutasteride market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
This report includes an overview of the development of the Dutasteride industry chain, the market status of Hospital (Type I, Type II), Drug Store (Type I, Type II), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Dutasteride.
Regionally, the report analyzes the Dutasteride markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Dutasteride market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Dutasteride market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Dutasteride industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Type I, Type II).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Dutasteride market.
Regional Analysis: The report involves examining the Dutasteride market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Dutasteride market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Dutasteride:
Company Analysis: Report covers individual Dutasteride manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Dutasteride This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Drug Store).
Technology Analysis: Report covers specific technologies relevant to Dutasteride. It assesses the current state, advancements, and potential future developments in Dutasteride areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Dutasteride market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Dutasteride market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Type I
Type II
Market segment by Application
Hospital
Drug Store
Major players covered
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dutasteride product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dutasteride, with price, sales, revenue and global market share of Dutasteride from 2019 to 2024.
Chapter 3, the Dutasteride competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dutasteride breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Dutasteride market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dutasteride.
Chapter 14 and 15, to describe Dutasteride sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Dutasteride
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dutasteride Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Type I
1.3.3 Type II
1.4 Market Analysis by Application
1.4.1 Overview: Global Dutasteride Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Drug Store
1.5 Global Dutasteride Market Size & Forecast
1.5.1 Global Dutasteride Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Dutasteride Sales Quantity (2019-2030)
1.5.3 Global Dutasteride Average Price (2019-2030)
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Dutasteride Product and Services
2.1.4 GSK Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Bionpharma
2.2.1 Bionpharma Details
2.2.2 Bionpharma Major Business
2.2.3 Bionpharma Dutasteride Product and Services
2.2.4 Bionpharma Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bionpharma Recent Developments/Updates
2.3 Rising Pharmaceuticals
2.3.1 Rising Pharmaceuticals Details
2.3.2 Rising Pharmaceuticals Major Business
2.3.3 Rising Pharmaceuticals Dutasteride Product and Services
2.3.4 Rising Pharmaceuticals Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Rising Pharmaceuticals Recent Developments/Updates
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Dutasteride Product and Services
2.4.4 Teva Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Teva Recent Developments/Updates
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Dutasteride Product and Services
2.5.4 Mylan Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Mylan Recent Developments/Updates
2.6 Zydus
2.6.1 Zydus Details
2.6.2 Zydus Major Business
2.6.3 Zydus Dutasteride Product and Services
2.6.4 Zydus Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Zydus Recent Developments/Updates
2.7 Amneal Pharma
2.7.1 Amneal Pharma Details
2.7.2 Amneal Pharma Major Business
2.7.3 Amneal Pharma Dutasteride Product and Services
2.7.4 Amneal Pharma Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Amneal Pharma Recent Developments/Updates
2.8 Apotex
2.8.1 Apotex Details
2.8.2 Apotex Major Business
2.8.3 Apotex Dutasteride Product and Services
2.8.4 Apotex Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Apotex Recent Developments/Updates
2.9 Marksans Pharma
2.9.1 Marksans Pharma Details
2.9.2 Marksans Pharma Major Business
2.9.3 Marksans Pharma Dutasteride Product and Services
2.9.4 Marksans Pharma Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Marksans Pharma Recent Developments/Updates
2.10 Breckenridge Pharmaceutical
2.10.1 Breckenridge Pharmaceutical Details
2.10.2 Breckenridge Pharmaceutical Major Business
2.10.3 Breckenridge Pharmaceutical Dutasteride Product and Services
2.10.4 Breckenridge Pharmaceutical Dutasteride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Breckenridge Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Dutasteride by Manufacturer
3.1 Global Dutasteride Sales Quantity by Manufacturer (2019-2024)
3.2 Global Dutasteride Revenue by Manufacturer (2019-2024)
3.3 Global Dutasteride Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Dutasteride by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Dutasteride Manufacturer Market Share in 2023
3.4.2 Top 6 Dutasteride Manufacturer Market Share in 2023
3.5 Dutasteride Market: Overall Company Footprint Analysis
3.5.1 Dutasteride Market: Region Footprint
3.5.2 Dutasteride Market: Company Product Type Footprint
3.5.3 Dutasteride Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Dutasteride Market Size by Region
4.1.1 Global Dutasteride Sales Quantity by Region (2019-2030)
4.1.2 Global Dutasteride Consumption Value by Region (2019-2030)
4.1.3 Global Dutasteride Average Price by Region (2019-2030)
4.2 North America Dutasteride Consumption Value (2019-2030)
4.3 Europe Dutasteride Consumption Value (2019-2030)
4.4 Asia-Pacific Dutasteride Consumption Value (2019-2030)
4.5 South America Dutasteride Consumption Value (2019-2030)
4.6 Middle East and Africa Dutasteride Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Dutasteride Sales Quantity by Type (2019-2030)
5.2 Global Dutasteride Consumption Value by Type (2019-2030)
5.3 Global Dutasteride Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Dutasteride Sales Quantity by Application (2019-2030)
6.2 Global Dutasteride Consumption Value by Application (2019-2030)
6.3 Global Dutasteride Average Price by Application (2019-2030)
7 North America
7.1 North America Dutasteride Sales Quantity by Type (2019-2030)
7.2 North America Dutasteride Sales Quantity by Application (2019-2030)
7.3 North America Dutasteride Market Size by Country
7.3.1 North America Dutasteride Sales Quantity by Country (2019-2030)
7.3.2 North America Dutasteride Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Dutasteride Sales Quantity by Type (2019-2030)
8.2 Europe Dutasteride Sales Quantity by Application (2019-2030)
8.3 Europe Dutasteride Market Size by Country
8.3.1 Europe Dutasteride Sales Quantity by Country (2019-2030)
8.3.2 Europe Dutasteride Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Dutasteride Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Dutasteride Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Dutasteride Market Size by Region
9.3.1 Asia-Pacific Dutasteride Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Dutasteride Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Dutasteride Sales Quantity by Type (2019-2030)
10.2 South America Dutasteride Sales Quantity by Application (2019-2030)
10.3 South America Dutasteride Market Size by Country
10.3.1 South America Dutasteride Sales Quantity by Country (2019-2030)
10.3.2 South America Dutasteride Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Dutasteride Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Dutasteride Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Dutasteride Market Size by Country
11.3.1 Middle East & Africa Dutasteride Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Dutasteride Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Dutasteride Market Drivers
12.2 Dutasteride Market Restraints
12.3 Dutasteride Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Dutasteride and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dutasteride
13.3 Dutasteride Production Process
13.4 Dutasteride Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dutasteride Typical Distributors
14.3 Dutasteride Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical
听
听
*If Applicable.
